News and Announcements
AIRSTAYZ™ announces key partnership and market entry updates in their latest investor update
- Published April 10, 2019 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Highlights
- AIRSTAYZ™ has officially announced a number of key partnerships and market entry updates in their latest Investor Update.
- Following a commercial agreement in 2018, they have announced an exclusive agreement with Simplenight®️ as steps to a complete merger (ostensibly, only subject to our capital raise).
- A Pre-Series A target of $6MM US has been set to fund necessary tech works and ongoing working capital.
AIRSTAYZ™ has officially announced a number of key partnerships and market entry updates in their latest Investor Update to ensure all Shareholders and Interested Groups have access to participate in ongoing capital raising.
Market Entry, Exclusive Agreements and Merger Talks
AIRSTAYZ™ is set to launch, and signed an exclusive agreement with Simplenight, following their signed commercial agreement in 2018. The two companies are looking to merge together in changing the travel game, plus with a merger will increase their combined market presence and cash flows.
China Partnership and 2019 Investment Deck
AIRSTAYZ™ have announced an official exclusive market entry with ABC World to execute a China Strategy with more information outlined in the Investment Deck, 2019.
Pre-Series A Capital Raise
With a capped $6MM US Pre-Series A target, AIRSTAYZ™ is seeking a timely $2MM US to take the company out of ‘bootstrap’ towards a fully funded operating company. The capital raised will fund necessary tech works, integrations and ongoing working capital.
About AIRSTAYZ™
AIRSTAYZ™ is a game-changer for the travel ecosystem. Blockchain-based loyalty in its best-use form, STAY is the utility token – the future currency for the Global Travel Ecosystem.
A groundbreaking project started in 2014, AIRSTAYZ™ is backed by strong industry Founders who are owners, operators and online distributors. Beta version already live, AIRSTAYZ™ with top partnerships secured: Simplenight, API’s (room supply), OpenTable (dining), OpenKey (digital key), Bellhop (share riding), Alluxe (luxury), Piñya™ (games), Delos (health), Marc Hotels® (hotels) which means formula for success. A stellar $1m ICO fundraise in June 2018, execution has been mapped through to completion of the Minimum Viable Product, go-to-market strategies in place, onboard of hotels & global supply – lastly STAY will be tradeable in the secondary cryptocurrency markets.
Company Updates
Arterial Alchemy: Turning the ‘Ticking Time Bomb’ of Heart Disease into Excretable Waste
Current heart medications thin the “grease” in our blood, but Atherid Therapeutics is building the first biological clearing agent to actually scrub the pipes clean. With human trials slated for 2027, the goal is to make heart attacks a preventable and reversible condition.
Breaking the ‘Bird’s Nest’: How Amplia Therapeutics is Piercing the Shield of Pancreatic Cancer
Led by award-winning drug developer Dr. Chris Burns, Amplia Therapeutics (ASX: ATX) is taking a “one-two punch” approach to one of medicine’s deadliest challenges. By utilizing their lead asset, narmafotinib, to dismantle the protective “bird’s nest” of fibrotic tissue surrounding pancreatic tumors, Amplia has achieved a 35% interim response rate in Phase 2a trials. With FDA Fast Track status and critical survival data expected in 2026, the company is rapidly approaching a major commercial and clinical rerate.
The Australian Life Science Sector: A Structural Convergence of 5 Critical Factors
For a decade, we have watched the foundation being built. Government grants are flowing into research infrastructure. Labs constructed. IP portfolios are growing. Talent returning from global pharma. For most of that decade, the returns were slow, the timelines were long, and the capital was cautious. That era is over. The Australian life science sector […]
Backed By Leading Investment Groups and Family Offices
